In an industry where $300B in rebates are managed through spreadsheets and emails, a 16-person team in Pennsylvania is building the operating system for pharmaceutical access. Quantuvis isn't just another SaaS tool—it's a full-stack rebellion against the archaic processes that define drug pricing negotiations.

"They're not building a feature—they're building the entire infrastructure for how Pharma and Payers actually get paid."

What makes Quantuvis dangerous is their focus on the entire workflow, not just a slice of it. While competitors might solve rebate tracking or contract management, Quantuvis owns the full lifecycle: rate setting, market access, compliance, and settlement. This end-to-end approach creates massive switching costs—once a Pharma company integrates their payer network into Quantuvis, extracting that data becomes nearly impossible.

• Full-stack platform: No integrations needed, it's the system of record
• Vertical focus: Purpose-built for Pharma/Payer dynamics, not generic workflow
• Network effects: Each new Payer on the platform increases value for all Pharma clients
• High switching costs: Data gravity keeps clients locked in once onboarded